What are the causes of Disseminated Intravascular Coagulation (DIC) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Disseminated intravascular coagulation (DIC) in pregnancy is most commonly caused by amniotic fluid embolism, placental abruption, severe preeclampsia, and HELLP syndrome, which trigger widespread clotting activation and consumption of clotting factors and platelets, resulting in paradoxical bleeding. The management of DIC in pregnancy requires treating the underlying cause while providing supportive care with blood products, as early recognition is crucial to reduce maternal mortality, especially when associated with obstetric hemorrhage 1.

Causes of DIC in Pregnancy

  • Amniotic fluid embolism: amniotic fluid enters maternal circulation, activating inflammatory and coagulation cascades 1
  • Placental abruption: placenta separates prematurely from the uterine wall, releasing tissue factor into maternal circulation
  • Severe preeclampsia and HELLP syndrome: cause endothelial damage and platelet activation
  • Retained dead fetus syndrome: fetal tissue breakdown products enter maternal circulation
  • Severe postpartum hemorrhage: depletes clotting factors

Management of DIC in Pregnancy

  • Treat the underlying cause
  • Provide supportive care with blood products, including packed red blood cells, fresh-frozen plasma, and platelets at a ratio of 1:1:1 (hemostatic resuscitation) 1
  • Early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols (GRADE 1C) 1
  • Consider the use of antifibrinolytics such as tranexamic acid or epsilon aminocaproic acid in cases of hyperfibrinolysis 1

Importance of Early Recognition

Early recognition of DIC in pregnancy is crucial to reduce maternal mortality, especially when associated with obstetric hemorrhage 1. Delayed diagnosis and treatment can lead to severe consequences, including organ failure and death. Therefore, it is essential to be aware of the causes and management of DIC in pregnancy to provide timely and effective care.

From the Research

Causes of DIC in Pregnancy

  • Obstetrical disorders such as abruptio placentae, eclampsia, retention of a dead fetus, amniotic fluid embolism, placental retention, and bacterial sepsis are common causes of DIC in pregnancy 2
  • Acute peripartum hemorrhage, placental abruption, preeclampsia/eclampsia/hemolysis, elevated liver enzymes, and low platelet count syndrome, retained stillbirth, septic abortion, and intrauterine infection are also associated with DIC 3
  • Other causes include amniotic fluid embolism, acute fatty liver of pregnancy, and severe preeclampsia 4, 5

Underlying Mechanisms

  • The etiopathogenesis of DIC is complex and currently thought to be initiated by tissue factor or thromboplastin, which is released from trophoblastic or fetal tissue, or maternal decidua or endothelium 5
  • Tissue factor activates the coagulation sequence to cause fibrin clotting and its dissolution by the fibrinolysin system, resulting in a range of clinical manifestations from mild laboratory derangements to marked coagulopathy with bleeding 5

Clinical Presentations

  • DIC patients can present with uncontrollable bleeding or multi-organ failure, which can be life-threatening 4
  • Clinical recognition of DIC varies by disease severity, and several organizations have attempted to standardize the diagnosis through development of scoring systems 5
  • A pregnancy-specific DIC score has been developed, which includes fibrinogen concentrations, prothrombin time difference, and platelet count, and has a high sensitivity and specificity for diagnosing DIC in pregnancy 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Disseminated intravascular coagulation in pregnancy.

The Journal of reproductive medicine, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.